Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Congress Should Open CBD Door, Close VMS Market Holes – Sharfstein, Cohen

Jun 14 2019

• By Malcolm Spicer

US map-cannibis-plants

Related Content

'Innovation' Meeting Shows FDA-Industry Gap On NDI Guidance Details Remains

May 20 2019

FDA Opens CBD Regulatory Path Docket, Warns Firms On Claims Missteps

Apr 03 2019

FDA Clearing CBD As Dietary Ingredient? Legislation More Likely Than Rulemaking

Apr 02 2019

FDA Road To Decision On Expanding CBD Uses Starts With Weighing Impact On Existing And Future Use As Drug

Jun 03 2019

Related Companies

GW Pharmaceuticals plc

Additional Topics

United States US States Dietary Supplements Legislation FDA Advertising, Marketing & Sales Business Strategies Commercial Compliance Drug Approval Standards Enforcement Ingredients Policy Regulation Safety Consumer

More from Legislation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window